copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
DEPO-PROVERA CI Depo-Provera CI is a progestin indicated for use by females of reproductive potential to prevent pregnancy (1) Limitations of Use: The use of Depo-Provera CI is not recommended as a long-term (i e , longer than 2 years) birth control method unless other options are considered inadequate (1, 5 1)
Depo-Provera Side Effects: Black Box Warning Tumor Risks Serious side effects may occur with Depo-Provera, though these are rarer, including bone density loss, increased risk of breast cancer and allergic reactions The prescription label has a black box warning, the FDA’s strongest warning, for loss of bone mineral density
DEPO-PROVERA® CI (medroxyprogesterone acetate injectable . . . - Medical DEPO-PROVERA® CI (medroxyprogesterone acetate injectable suspension, for intramuscular use) medication page for patients to search for scientific information prescribing information about Pfizer medications in the US
Depo-Provera (Medroxyprogesterone): Side Effects, Uses, Dosage . . . - RxList What Is Depo-Provera? Depo- Provera (medroxyprogesterone acetate) is a form of progesterone, a female hormone used as contraception to prevent pregnancy Depo-Provera is also used to reduce pain cause by endometriosis, and to ease pain and symptoms in women with metastatic uterine or kidney cancer Depo-Provera is available in generic form
Depo Provera Brain Tumor Warning: Why The FDA Changed The Label And . . . US News Depo Provera Brain Tumor Warning: Why The FDA Changed The Label And What It Means For Users Authored by: Yuvraj Tyagi Updated Dec 18, 2025, 01:03 IST The FDA approved a label update Friday for Pfizer's Depo-Provera birth control shot warning of meningioma—a brain tumor in the lining—after studies dating back to 1983 linked high-dose progestin to the risk